$XAIR In a spitting distance from a 52 week high, the stock flexing its muscles ahead of the FDA approval. Given the recent insider purchases and the seasoned team that is working to ensure clean path for approval - the gigantic leap towards the double digit zone is imminent and inevitable. Wish us luck
1
4
4 Likes